According to Dr. John Abramson, pharmaceutical companies, medical journals, and federal health agencies have conflicts of interest that would harm the public “tremendously.”
The problem has been demonstrated by how clinical trial data is being handled, said Abramson, a Havard Medical School lecturer and an expert in litigation.
“It’s a system that is inherently nonsensical,” Abramson said in a recent interview with EpochTV’s “Facts Matter” program.
Abramson explained that Big Pharma funds most of the clinical trials, and its influence could allow the data to be presented in a way that is in their best interest—selling more products. However, peer-reviewed medical journals don’t have complete data access and can’t guarantee the integrity of those studies. Government agencies also play a role in advancing Big Pharma’s agenda. These factors could lead doctors to prescribe or patients to accept a medical product without knowing its full risk….